Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request

Análise da revisão Cochrane : implantes de corticóides na uveíte não-infecciosa crónica : Cochrane Database Syst Rev. 2016;2:CD010469 ; Analysis of the Cochrane review : cortisteroid implants for chronic non-infectious uveitis : Cochrane Database Syst Rev. 2016;2:CD010469

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
  • معلومة اضافية
    • بيانات النشر:
      Ordem dos Médicos
    • الموضوع:
      2018
    • Collection:
      Technical University of Lisbon: UTL Repository / Universidade Técnica de Lisboa
    • نبذة مختصرة :
      Copyright © Ordem dos Médicos 2018 ; Non-infectious uveitis is a heterogeneous collection of inflammatory eye diseases and is one of the most important causes of blindness among active adults in developed countries. Inflammation control is crucial in the prevention of ocular structural and functional damage. Regarding acute inflammatory control, corticosteroids are the mainstay of treatment. Several types of intra-ocular corticosteroids have been used with the aim of enhanced efficacy compared to their topical or peri-ocular administration, while minimizing its adverse effects associated with the systemic administration. The purpose of this Cochrane review was to synthetize the available evidence regarding the efficacy and safety of corticosteroid implants in comparison with standard treatment. Due to the heterogeneity in the design of the studies and outcome measures assessed, authors could not conclude that implants are superior to traditional systemic therapy in Non-infectious uveitis. The safety analysis suggested increased risks of post-implant surgery for cataract and high intraocular pressure compared with standard-of-care therapy. ; A uveíte não infecciosa inclui várias patologias com elevada morbilidade, sendo uma das causas mais importantes de cegueira na população activa de países desenvolvidos. O controlo da inflamação é essencial na prevenção do dano estrutural e funcional às estruturas oculares. Sendo os corticóides fármacos de primeira linha no controlo agudo da inflamação, têm sido usadas formulações intra-oculares destes fármacos, com o objectivo de aumentar a eficácia face ao uso tópico ou periocular e de induzir menos efeitos adversos secundários comparativamente ao uso sistémico. O objectivo desta revisão Cochrane foi sintetizar a evidência existente sobre a eficácia e segurança de implantes de corticóides intravítreos, em comparação com a terapêutica convencional. Devido à heterogeneidade no desenho e medidas de eficácia utilizadas, os autores não conseguiram demonstrar superioridade dos ...
    • Relation:
      https://www.actamedicaportuguesa.com/revista/index.php/amp/index; http://hdl.handle.net/10451/33721
    • الرقم المعرف:
      10.20344/amp.10660
    • الدخول الالكتروني :
      http://hdl.handle.net/10451/33721
      https://doi.org/10.20344/amp.10660
    • Rights:
      openAccess
    • الرقم المعرف:
      edsbas.E9F0C640